High-Purity N-Palmitoyl-L-Glutamic Acid Derivative Supplier: Advanced Pharmaceutical Intermediates

Discover the critical role of N-Palmitoyl-L-Glutamic Acid γ-Succinimidyl-α-tert-butyl Ester (CAS 204521-63-1) in advancing pharmaceutical research. We are a leading manufacturer and supplier, providing this high-purity intermediate for the development of innovative drug therapies.

Get a Quote & Sample

Why Choose Our N-Palmitoyl-L-Glutamic Acid Derivative?

Superior Purity for Pharmaceutical Efficacy

Our N-Palmitoyl-L-Glutamic Acid γ-Succinimidyl-α-tert-butyl Ester boasts a purity of ≥99%, ensuring optimal performance in complex pharmaceutical synthesis and formulation, crucial for GLP-1 derivative production.

Expertise in Pharmaceutical Intermediates

Leveraging extensive experience, we supply this key building block for innovative antiobesity agents and treatments for metabolic disorders, acting as a dedicated pharmaceutical intermediates supplier.

Reliable Supply Chain & Competitive Pricing

As a prominent manufacturer, we offer a stable supply and competitive price for CAS 204521-63-1, supporting your procurement needs for peptide synthesis and drug delivery research. Contact us for a quote.

Key Applications in Pharmaceutical Development

Development of Long-Acting GLP-1 Agonists

Critical for synthesizing lipophilic human glucagon-like peptide-1 derivatives, enhancing their duration of action for metabolic disease management.

Antiobesity Agent Manufacturing

Serves as a vital raw material for the production of modern antiobesity drugs, contributing to weight management therapies.

Advanced Drug Delivery Systems

Enables the formulation of sophisticated drug delivery systems that improve bioavailability and therapeutic efficacy through lipophilic modification.

Peptide Synthesis and Modification

An essential intermediate for precise peptide synthesis and modification, allowing for tailored properties in therapeutic peptides.